Cannabis Europa is excited to announce EMMAC Life Sciences as a Silver Partner for our London conference this June at the Southbank Centre.
EMMAC Life Sciences is an independent European medical cannabis company, combining the latest science and research with cutting-edge cultivation, extraction and production.
Spearheading Relief for UK Patients
This April, EMMAC announced the acquisition of Rokshaw, a leading UK Specials manufacturer, enabling the company to import medical cannabis into the UK to meet the growing demand for premium medical cannabis products. EMMAC aims to close the gap between cannabis policy reform and the subsequent lack of patients access to medical cannabis across Europe.
“This investment provides EMMAC instant access to the UK medical cannabis market with the opportunity to grow the existing 45 people-strong team into a centre of medical cannabis excellence for the UK.” Antonio Costanzo, CEO EMMAC
Their UK laboratory has already manufactured more than 6,000 formulations for over 2,000 pharmacies and hospitals across the UK. It holds the following licences: MHRA Specials Manufacturing, Home Office Controlled Drugs Schedule 2 and Wholesale Dealers Authorisation, which ensures that compliant product can be imported and manufactured in the UK in order to meet the growing demand for cannabis-based products for medicinal use (“CBPMs”).
Thought Leader in Europe
Led by seasoned industry executives and consultants, EMMAC is an industry leader in the UK and European medical cannabis space. With supply and distribution partnerships throughout Europe, EMMAC is working to establish itself as both a thought leader in the industry, as well as the European leader in the production and supply of medical cannabis, hemp, and other derivative products. EMMAC is joining Cannabis Europa on June 24th-25th in London for panels that will address pertinent and efficient questions to drive medical cannabis in Europe forward.
“It is an exciting time for the cannabis industry in Europe and we look forward to discussing how EMMAC is capitalising on the opportunities presented by this rapidly evolving market.”
– Antonio Costanzo, CEO EMMAC and speaker at Cannabis Europa Paris 2018
Join us at the Southbank Centre for vibrant discussions on future research possibilities, the role of clinical trials and how we can work with scientists and regulators to push legislation forward.
Cannabis Europa will take place on June 24th and 25th as part of the inaugural European Cannabis Week.
